Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Therapeutic Effects of Berberine Plus Sitagliptin in a Rat Model of Fatty Liver Disease Publisher



Mehrdoost S1 ; Yaghmaei P1 ; Jafary H1 ; Ebrahimhabibi A2, 3
Authors

Source: Iranian Journal of Basic Medical Sciences Published:2021


Abstract

Objective(s): Fatty liver disease (FLD) is a disorder related to accumulation of excess fat within the hepatocytes. In this study, the effects of berberine, a natural compound, and sitagliptin as a DPP-4 inhibitor, were observed in a rat model of FLD. Materials and Methods: Forty male rats were divided into five groups (n=6) including the control group (normal food and water), high-fat group (high-fat diet (HF) for 6 weeks), berberine group (HF with oral administration of berberine at 150 mg/kg for 6 weeks), sitagliptin group (HF with oral administration of sitagliptin at 10 mg/kg for 6 weeks), and berberine/ sitagliptin group (HF diet within combination with oral administration of berberine 75 mg/kg and sitagliptin 5 mg/kg for 6 weeks). Animals were examined for weight gain, serum and hepatic biochemical parameters, tissue histology, expression of glucose transporter type 4 (GLUT4) mRNA, and protein expression of Adiponectin receptor2 (AdipoR2) and extracellular signal-regulated kinase (ERK) and phoERK. Results: The results showed that ALT, AST, lipid profile, insulin, glucose, MDA, and TNF-α were significantly improved in high-fat rats treated with berberine/ sitagliptin compared with HF and sitagliptin, and berberine alone groups. SOD and adiponectin levels in berberine/ sitagliptin group were also significantly increased compared with the other groups. Immunoblot analysis showed that the expression of pho-ERK/ERK was significantly decreased and expression of AdipoR2 significantly increased in the berberine/ sitagliptin group compared with other groups. Conclusion: Co-administration of berberine and sitagliptin is an effective therapeutic regimen for conditions associated with hyperlipidemia. © 2021 Mashhad University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. A Randomized Triple-Blind Controlled Clinical Trial Evaluation of Sitagliptin in the Treatment of Patients With Non-Alcoholic Fatty Liver Diseases Without Diabetes, Frontiers in Medicine (2022)
2. Recent Advances in Dietary Supplementation, in Treating Non-Alcoholic Fatty Liver Disease, World Journal of Hepatology (2015)
3. A Simple Method for Inducing Nonalcoholic Steatohepatitis With Fibrosis, Animal Models and Experimental Medicine (2019)
Experts (# of related papers)
View all Related Experts
Azadeh Ebrahim-Habibi (3)
Reza Meshkani (3)
Other Related Docs
4. Development of a Novel Anti-Obesity Compound With Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes, Iranian Biomedical Journal (2020)
5. The Combination of Metformin With Morin Alleviates Hepatic Steatosis Via Modulating Hepatic Lipid Metabolism, Hepatic Inflammation, Brown Adipose Tissue Thermogenesis, and White Adipose Tissue Browning in High-Fat Diet-Fed Mice, Life Sciences (2023)
6. Combination of Metformin and Genistein Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Fed Mice, Journal of Nutritional Biochemistry (2021)
7. In-Vitro Synergistic Effect of Metformin and Berberine on High Glucose-Induced Lipogenesis, Iranian Journal of Pharmaceutical Research (2019)
8. Role of the Liver Capsule As a Traditional Medicine Formulation in the Treatment of Non-Alcoholic Fatty Liver Disease in Rats, Pharmaceutical Chemistry Journal (2024)
9. The Effects of Green Cardamom on Blood Glucose Indices, Lipids, Inflammatory Factors, Paraxonase-1, Sirtuin-1, and Irisin in Patients With Nonalcoholic Fatty Liver Disease and Obesity: Study Protocol for a Randomized Controlled Trial, Trials (2017)
10. Effect of Thioflavin-T on Adipokine Hormones and Fatty Liver in Obese Male Nmri Mice Fed a High-Fat Diet, Physiology and Pharmacology (Iran) (2024)
11. The Effect of Berberine Supplementation on Obesity Indices: A Dose– Response Meta-Analysis and Systematic Review of Randomized Controlled Trials, Complementary Therapies in Clinical Practice (2020)
12. A Review of the Available Remedial Procedures for the Treatment of Fatty Liver Disease, Pakistan Journal of Medical and Health Sciences (2020)
13. Associations of Dietary Fats Intake and Adipokines Levels in Obese Women, Clinical Nutrition ESPEN (2021)
14. Biochemical and Histopathological Evidence on Beneficial Effects of Standardized Extract From Tragopogon Graminifolius As a Dietary Supplement in Fatty Liver: Role of Oxidative Stress, Journal of Dietary Supplements (2018)
15. Effectiveness of Dietary Interventions on Cardio-Metabolic Risk Factors in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Annals of Gastroenterology (2021)
16. Allium Sativum: A Potential Natural Compound for Nafld Prevention and Treatment, Frontiers in Nutrition (2023)
17. Glycyrrhizin Improves Fatty Liver Symptoms, Increases Adiponectin and Reduces Ucp2 Expression in Wistar Rats, Proceedings of the National Academy of Sciences India Section B - Biological Sciences (2020)
18. The Effects of Curcumin Supplementation on Liver Enzymes, Lipid Profile, Glucose Homeostasis, and Hepatic Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease, European Journal of Clinical Nutrition (2019)
19. The Effect of Metformin on Adipokines Levels: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials, Diabetes Research and Clinical Practice (2024)
20. The Effect of Soy Isoflavones Supplementation on Metabolic Status in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Placebo Controlled Clinical Trial, BMC Public Health (2024)